Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 199 for:    Venetoclax

A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03797261
Recruitment Status : Suspended (Suspended to evaluate safety)
First Posted : January 9, 2019
Last Update Posted : October 1, 2019
Sponsor:
Collaborators:
Genentech, Inc.
Amgen
Information provided by (Responsible Party):
AbbVie

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : September 2, 2022
Estimated Study Completion Date : September 2, 2022